NIPTE Awarded $35 Million in Funding from the FDA

Sep. 25, 2017

The National Institute for Pharmaceutical Technology and Education (NIPTE), which boasts Medicinal Chemistry's own Dr. Vadim Gurvich as executive director, was recently awarded $35 million dollars in funding from the Food and Drug Administration, to be allocated over a 5-year period. The grant will support a multitude of different projects in the pharmaceutical field from improvements in manufacturing and technology to research and education.

"We are very excited about the opportunity to continue this collaboration with the U.S. FDA," explains Dr. Gurvich, who is also the principal investigator on the grant. "The funding allows NIPTE faculty to contribute their research expertise, helping the FDA create policies in critical areas such as quality by design of complex pharmaceutical products, characterization of pharmaceutical materials, and formulation strategies like abuse deterrent products to combat opioid abuse. In addition, NIPTE will also address topics such as Quality Metrics and Quality Score Card as tools to improve surveillance and risk-based decisions. This brings our decade-long collaboration with the FDA to the next level, allowing us to make a bigger impact on quality, safety, and affordability of pharmaceutical products."

 
Read more about the grant here.